Tamoxifen citrate Prescribing at PRIORY SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
90
Total Quantity
5,264
NHS Cost
£435
vs National Avg
+9.3%
PRIORY SURGERY prescribed 90 items of Tamoxifen citrate over the last 12 months at a cost of £435 to the NHS. This is 9.3% above the national average prescribing rate. Tamoxifen citrate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
5
Jul 2026
9
Jul 2026
4
Jul 2026
10
Jul 2026
3
Jul 2026
12
Jul 2026
2
Jul 2026
14
Jul 2026
6
Jul 2026
7
Jul 2026
8
Jul 2026
10
Prescribing Details
| Total Items | 90 |
|---|---|
| Total Quantity | 5,264 |
| Total NHS Cost | £435 |
| Presentations | 1 different forms |
| vs National Average | +9.3% |
Tamoxifen citrate Prescribing Comparison
| This practice | 90 items |
|---|---|
| National average per practice | 82 items |
| Difference | +9.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.